Literature DB >> 19443808

Beta-amyloid, blood vessels, and brain function.

Eric E Smith1, Steven M Greenberg.   

Abstract

Cerebrovascular disease and Alzheimer disease are common diseases of aging and frequently coexist in the same brain. Accumulating evidence suggests that the presence of brain infarction, including silent infarction, influences the course of Alzheimer disease. Conversely, there is evidence that beta-amyloid can impair blood vessel function. Vascular beta-amyloid deposition, also known as cerebral amyloid angiopathy, is associated with vascular dysfunction in animal and human studies. Alzheimer disease is associated with morphological changes in capillary networks, and soluble beta-amyloid produces abnormal vascular responses to physiological and pharmacological stimuli. In this review, we discuss current evidence linking beta-amyloid metabolism with vascular function and morphological changes in animals and humans.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19443808      PMCID: PMC2704252          DOI: 10.1161/STROKEAHA.108.536839

Source DB:  PubMed          Journal:  Stroke        ISSN: 0039-2499            Impact factor:   7.914


  72 in total

Review 1.  Proinflammatory and vasoactive effects of Abeta in the cerebrovasculature.

Authors:  K P Townsend; D Obregon; A Quadros; N Patel; Ch Volmar; D Paris; M Mullan
Journal:  Ann N Y Acad Sci       Date:  2002-11       Impact factor: 5.691

2.  Toxicity of Dutch (E22Q) and Flemish (A21G) mutant amyloid beta proteins to human cerebral microvessel and aortic smooth muscle cells.

Authors:  Z Wang; R Natté; J A Berliner; S G van Duinen; H V Vinters
Journal:  Stroke       Date:  2000-02       Impact factor: 7.914

3.  Capillary beds are decreased in Alzheimer's disease, but not in Binswanger's disease.

Authors:  Hiroshi Kitaguchi; Masafumi Ihara; Hidemoto Saiki; Ryosuke Takahashi; Hidekazu Tomimoto
Journal:  Neurosci Lett       Date:  2007-02-11       Impact factor: 3.046

4.  Cerebral amyloid angiopathy and cortical microinfarcts as putative substrates of vascular dementia.

Authors:  Mattias Haglund; Ulla Passant; Martin Sjöbeck; Estifanos Ghebremedhin; Elisabet Englund
Journal:  Int J Geriatr Psychiatry       Date:  2006-07       Impact factor: 3.485

5.  Exogenous A beta1-40 reproduces cerebrovascular alterations resulting from amyloid precursor protein overexpression in mice.

Authors:  K Niwa; G A Carlson; C Iadecola
Journal:  J Cereb Blood Flow Metab       Date:  2000-12       Impact factor: 6.200

Review 6.  Mechanism of cerebral beta-amyloid angiopathy: murine and cellular models.

Authors:  Martin C Herzig; William E Van Nostrand; Mathias Jucker
Journal:  Brain Pathol       Date:  2006-01       Impact factor: 6.508

7.  Stereologic analysis of microvascular morphology in the elderly: Alzheimer disease pathology and cognitive status.

Authors:  Constantin Bouras; Enikö Kövari; François R Herrmann; Claire-Bénédicte Rivara; Thomasina L Bailey; Armin von Gunten; Patrick R Hof; Panteleimon Giannakopoulos
Journal:  J Neuropathol Exp Neurol       Date:  2006-03       Impact factor: 3.685

8.  Only cerebral capillary amyloid angiopathy correlates with Alzheimer pathology--a pilot study.

Authors:  Johannes Attems; Kurt A Jellinger
Journal:  Acta Neuropathol       Date:  2003-12-04       Impact factor: 17.088

9.  Capillary cerebral amyloid angiopathy is associated with vessel occlusion and cerebral blood flow disturbances.

Authors:  Dietmar Rudolf Thal; Estibaliz Capetillo-Zarate; Sergey Larionov; Matthias Staufenbiel; Stefan Zurbruegg; Nicolau Beckmann
Journal:  Neurobiol Aging       Date:  2008-03-21       Impact factor: 4.673

10.  Cerebral hypoperfusion generates cortical watershed microinfarcts in Alzheimer disease.

Authors:  Oda-Christina Suter; Thanomphone Sunthorn; Rudolf Kraftsik; Joel Straubel; Pushpa Darekar; Kamel Khalili; Judith Miklossy
Journal:  Stroke       Date:  2002-08       Impact factor: 7.914

View more
  103 in total

1.  Brain energy metabolism and blood flow differences in healthy aging.

Authors:  Joel Aanerud; Per Borghammer; M Mallar Chakravarty; Kim Vang; Anders B Rodell; Kristjana Y Jónsdottir; Arne Møller; Mahmoud Ashkanian; Manouchehr S Vafaee; Peter Iversen; Peter Johannsen; Albert Gjedde
Journal:  J Cereb Blood Flow Metab       Date:  2012-02-29       Impact factor: 6.200

2.  Autoimmune encephalopathy.

Authors:  Richard J Caselli; Joseph F Drazkowski; Dean M Wingerchuk
Journal:  Mayo Clin Proc       Date:  2010-10       Impact factor: 7.616

3.  Substituted dithiazole piperazine benzamides as novel amyloid beta peptide reducing agents.

Authors:  Hongjie Wang; Ruizhi Wang; Madepalli K Lakshmana; Adel Nefzi
Journal:  Bioorg Med Chem Lett       Date:  2014-08-13       Impact factor: 2.823

Review 4.  Clinical syndromes and management of intracerebral hemorrhage.

Authors:  Sang-Bae Ko; H Alex Choi; Kiwon Lee
Journal:  Curr Atheroscler Rep       Date:  2012-08       Impact factor: 5.113

5.  Identification of neurovascular changes associated with cerebral amyloid angiopathy from subject-specific hemodynamic response functions.

Authors:  Rebecca J Williams; Bradley G Goodyear; Stefano Peca; Cheryl R McCreary; Richard Frayne; Eric E Smith; G Bruce Pike
Journal:  J Cereb Blood Flow Metab       Date:  2017-02-01       Impact factor: 6.200

6.  Alzheimer's disease peptide beta-amyloid interacts with fibrinogen and induces its oligomerization.

Authors:  Hyung Jin Ahn; Daria Zamolodchikov; Marta Cortes-Canteli; Erin H Norris; J Fraser Glickman; Sidney Strickland
Journal:  Proc Natl Acad Sci U S A       Date:  2010-11-22       Impact factor: 11.205

7.  Recurrence of Lobar Hemorrhage: A Red Flag for Cerebral Amyloid Angiopathy-related Inflammation?

Authors:  Vaibhav Rastogi; Lauren L Donnangelo; Ganesh Asaithambi; Sharatchandra Bidari; Anna Y Khanna; Vishnumurthy Shushrutha Hedna
Journal:  Innov Clin Neurosci       Date:  2015 May-Jun

8.  Cerebral amyloid angiopathy in an aged sooty mangabey (Cercocebus atys).

Authors:  Olivia M D'Angelo; Jeromy Dooyema; Cynthia Courtney; Lary C Walker; Eric Heuer
Journal:  Comp Med       Date:  2013       Impact factor: 0.982

9.  Pittsburgh Compound-B (PiB) binds amyloid β-protein protofibrils.

Authors:  Ghiam Yamin; David B Teplow
Journal:  J Neurochem       Date:  2016-12-12       Impact factor: 5.372

Review 10.  Transgenic models for cytokine-induced neurological disease.

Authors:  Iain L Campbell; Markus J Hofer; Axel Pagenstecher
Journal:  Biochim Biophys Acta       Date:  2009-10-14
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.